The University of Texas at Dallas Features 14 New Technologies on Pharmalicensing.com – A Global Life Sciences Technology Marketplace
TAMPA, Fla. (PRWEB) June 01, 2018 -- Pharmalicensing.com, the largest online global life science technology marketplace, announces The University of Texas at Dallas as a new member featuring their commercially available technologies on the forum.
The technologies posted by UT Dallas have come from a wide variety of multidisciplinary research efforts, including innovative prosthetic/orthotic work from Dr. Robert Gregg, a recipient of an NSF Faculty Early Career Development Award, who develops high-performance wearable control systems to improve the quality of life for persons with disabilities. Additionally, UT Dallas’ Pain Neurobiology Research Group (https://www.utdallas.edu/bbs/painneurosciencelab/) is working with industry partners to develop non-opioid pain therapeutics for the treatment/prevention of acute and chronic pain.
“UT Dallas is pleased to join the Pharmalicensing portal as a way to demonstrate our expertise in a variety of life science fields and expand our outreach in seeking licensing partners,” said Brent Schultze, director of technology commercialization at UT Dallas. “Our close relationship with UT Southwestern Medical Center and our interdisciplinary approach has led to significant advances resulting in point-of-care diagnostic devices, improved standards for clinical pain research, and novel biomarkers for one-step identification of cancer stem cells.”
Pharmalicensing.com (http://www.pharmalicensing.com), a division of Cognis Group, is an online marketplace providing self-directed solutions for those seeking scouting and partnering opportunities. Used by technology transfer officers, technology scouts, business development professionals, research universities, and government institutions spanning 110 countries, it is the largest repository of life science opportunities in the world, with over 23,000 licensable technologies. For more than 20 years, the company has fostered commercialization within the life science, pharmaceutical, and medical device industries – providing a forum for members, like UT Dallas, to create awareness of technologies, explore hyper-targeted search results, engage relevant scouts, and benefit from opportunity assessment analytics.
ABOUT COGNIS GROUP
Cognis Group, based in the US and UK, is an innovation consultancy specializing in all facets of Intellectual Property, Commercialization, and Foresight Research. We provide organizations around the world with the business intelligence and experience they need to make important innovation decisions with confidence. With 20 years of experience, Cognis provides services and solutions to Fortune 500 companies, research universities, institutions, and technology owners. http://www.cognisgroup.com
Nissa Weisser, Cognis Group, http://www.cognisgroup.com, +1 813-971-8273 Ext: 226, [email protected]
Share this article